Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 2/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4795989 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL15435982 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL15436002 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL10767543 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL758333 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL1427803 | 0.95 | CETP (0.43) | LDHA | |
| SCHEMBL717379 | 0.94 | LDHA (0.41) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL744429 | 0.94 | AKT1 (0.42) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL5677688 | 0.94 | VEGFA (0.42) | AKT1LDHAVEGFA | |
| SCHEMBL15435989 | 0.92 | AKT1 (0.42) | AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021011538-A1 | CAPSULE DOSAGE FORMS, METHODS OF PREPARATION AND METHODS OF USE THEREOF | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2021-01-21 | — | — | WO | claimed |
| EP-1536701-A1 | USE OF SURFACTANTS TO SOLUBILIZE WATER-INSOLUBLE SOLIDS IN BEVERAGES | PepsiCo, Inc. (US) | 2005-06-08 | — | — | EP | claimed |
| WO-2004023900-A1 | USE OF SURFACTANTS TO SOLUBILIZE WATER-INSOLUBLE SOLIDS IN BEVERAGES | PEPSICO, INC. (US) | 2004-03-25 | — | — | WO | claimed |
| EP-0345246-B1 | Tissue adhesive | IMMUNO AG (AT) | 1993-12-15 | — | — | EP | claimed |
| US-4909251-A | Tissue adhesive | IMMUNO AKTIENGESELLSCHAFT FUR CHEMISCH-MEDIZINISCHE PRODUKTE (AT) | 1990-03-20 | — | — | US | claimed |
| EP-4637685-A1 | COMPOSITION WITH CHITOSAN | L'OREAL (FR) | 2025-10-29 | — | — | EP | disclosed |
| CN-118401231-A | Composition for keratin fibres | 莱雅公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024133196-A1 | COMPOSITION WITH CHITOSAN | L'OREAL (FR) | 2024-06-27 | — | — | WO | disclosed |
| EP-3891102-B1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | CARBONET NANOTECHNOLOGIES INC (CA) | 2024-04-17 | — | — | EP | disclosed |
| EP-3644948-B1 | ANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERS | OREAL (FR) | 2023-09-13 | — | — | EP | disclosed |
| CN-116419741-A | Composition for conditioning keratin materials | 莱雅公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116367808-A | Composition for conditioning keratin materials | 莱雅公司 | 2023-06-30 | — | — | CN | disclosed |
| US-4946832-A | SUCROSE FATTY ACID ESTER AND ACYL FATTY ACID ALPHA-HYDROXY CARBOXYLIC ACID | R.I.T.A. CORPORATION (US) | 1990-08-07 | — | — | US | disclosed |
| EP-0371601-A2 | Surfactant | CADBURY SCHWEPPES PLC (GB) | 1990-06-06 | — | — | EP | disclosed |
| EP-0305493-A4 | COSMETIC BASE COMPOSITION WITH THERAPEUTIC PROPERTIES. | R I T A CORP (US) | 1990-02-22 | — | — | EP | disclosed |
| US-4822601-A | MIXTURE OF SUCROSE FATTY ACID ESTER AND ACYL FATTY ACID LACTYLATE ESTER | R.I.T.A. CORPORATION (US) | 1989-04-18 | — | — | US | disclosed |
| EP-0305493-A1 | COSMETIC BASE COMPOSITION WITH THERAPEUTIC PROPERTIES. | R I T A CORP (US) | 1989-03-08 | — | — | EP | disclosed |
| US-4774178-A | Immobilization of biological material within a polymer matrix | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-27 | — | — | US | disclosed |
| WO-1988006880-A1 | COSMETIC BASE COMPOSITION WITH THERAPEUTIC PROPERTIES | R.I.T.A. CORPORATION (US) | 1988-09-22 | — | — | WO | disclosed |
| US-4656161-A | Increasing the enteral absorbability of heparin or heparinoids | BASF AKTIENGESELLSCHAFT (DE) | 1987-04-07 | — | — | US | disclosed |